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EUROSTAR collaborators Trondheim, Norway; and Eindhoven, The Netherlands
Purpose: To investigate the early and late outcome after endovascular treatment of abdominal aortic aneurysm (EVAR) in
octogenarians compared with patients aged <80 years.
Methods: Patients treated for abdominal aortic aneurysm (AAA) with endovascular repair during the period 1996 to 2004
were collated in the EUROSTAR registry. This study group consisted of 697 patients aged >80 years. Comparison was
made with 4198 patients aged<80 years with regard to the incidence of preoperative characteristics and outcomes of the
procedure.
Results: The proportion of octogenarians treated by EVAR increased during the study period, from 11% in the first year
to 18% in the last year. Octogenarians more frequently had cardiac disease, impaired renal function, and pulmonary
disease (P .03, P< .0001 and P .0001). Thirty-two percent of the octogenarians were recorded unfit for open surgery
as opposed to 22% in younger patients (P< .0001); they also had a larger aneurysm diameter (62 vs 58 mm, respectively;
P< .0001). The 30-day and in-hospital mortality in octogenarians was 5% vs 2% in the younger group (P< .0001). More
device-related complications and systemic complications, including cardiac disease, were noted in octogenarians (7% vs 5%
and 19% vs 11%, P .03 and P< .0001, respectively). This group of patients also had a higher incidence of postoperative
hemorrhagic complications, including hematoma (7% vs 3%, P < .0001, respectively). No differences in conversion to
open repair and post-EVAR rupture rate were observed. Aneurysm-related mortality and late all-cause mortality was 7%
vs 3% and 10% vs 7%, both P < .0001.
Conclusion:Our study supports that EVARmight be considered when treating elderly patients, provided their aneurysms
are anatomically suited for the endovascular technique. The risk for late complications compared with open repair may be
outweighed by a lower early mortality as well as a shorter time for physical recovery. (J Vasc Surg 2005;:.)Abdominal aortic aneurysm (AAA) is an age-related
disease accounting for 1% to 2% of all deaths.1 The overall
life expectancy of the population is increasing, and projec-
tions are that more elderly patients will present for AAA
repair in the future. Elective operation is the most impor-
tant measure to prevent rupture and death, but the risk of
an open operation is considerable in octogenarians. Even in
selected subcohorts, operative mortality rates of 5% to 10%
were observed.2-8 Open repair in patients aged80 years is
often not even considered because of comorbidities or their
advanced age in itself.
Endovascular abdominal aortic aneurysm repair
(EVAR) has emerged as an appealing alternative in patients
with, on the one hand, an AAA with a high risk of rupture
and, on the other hand, a reasonable life expectancy. So far,
the results of EVAR for single institutions have included
only a limited number of patients aged80 years.9-15 Our
objective was to study early and late outcome following
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MATERIAL AND METHODS
Patients were recruited from 153 European institutions
(Appendix available online). Only commercially available
Communauté Europeénne (CE) approved stent grafts were
applied. Two categories were distinguished: patients aged
80 years and patients 80 years. There were no differ-
ences in device distribution between the two groups.
Baseline data included information about patient co-
morbidity, fitness for open surgery, American Society of
Anaesthesiologists (ASA) classification, and aneurysm anat-
omy. Operative aspects were assessed. The information was
recorded by the participating institutions on case record
forms and submitted to the EUROSTAR Data Register
Center. Since 2001, most of the data submission has been
performed by the EUROSTAR website, www.eurostar-
online.org (design and maintenance by KIKA-medical,
Nancy, France).
Patients were enrolled in the EUROSTAR registry on
an intention-to-treat manner. Inclusion criteria, as defined
in the EUROSTAR protocol, comprised elective treatment
for AAA and a vascular anatomy suitable for the implanta-
tion of a stent graft. Follow-up investigation included a
clinical examination, contrast enhanced computed tomog-
raphy (CT) of the abdomen, and in a minority of cases
(4%), angiography or magnetic resonance imaging.
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involvement of a core laboratory for evaluation of CT scans
or other imaging investigations.
Preoperative risk assessment consisted of ASA class,
ankle-brachial index, Society of Vascular Surgery SVS/
International Society for Vascular Specialists risk scores,
previous laparotomy, obesity, estimate of fitness for open
AAA repair and general anaesthesia,16 method of preoper-
ative examination, iliac artery patency by angiography, an-
atomic aortic diameter and length measurements, arterial
angulation, and AAA classification (degree of iliac involve-
ment).17 Arterial diameters were measured from adventitia
to adventitia. The diameter of the aneurysm was measured
as its largest section between the outer walls on the axial CT
slices. Angulations were considered significant when at least
60°. Procedural details, including date of operation, device
make, type of anesthesia, device configuration, procedural
duration, and endoleaks at the completion angiography
were recorded.
Early complications included intraoperative device-
related problems, inability to advance the delivery system,
inability to deploy the device, stent-graft migration, occlu-
sion, stenosis, or arterial injuries. Postoperative systemic
complications, including cardiac, pulmonary, and renal
function impairment, were recorded.
Primary technical success was defined as complete ex-
clusion of the aneurysm. Patients were followed up at 1, 6,
12, 18, 24 months, and annually thereafter. Satisfactory
finding at CT was defined by absence of endoleak, stent-
graft migration, kinking, stenosis, thrombosis, and aneu-
rysm expansion. Outcome reporting was performed ac-
cording to the guidelines from the ad hoc committee for
standardized reporting practices in vascular surgery of the
Society for Vascular Surgery/American Association for
Vascular Surgery.18 Other outcome events observed during
follow-up included endoleak, graft migration, device disin-
tegration, and continuing aneurysm expansion.
Data were presented as means and ranges. Missing data
were indicated as such in the tables. Deaths occurring30
days of the initial procedure were categorized as operative
deaths; and deaths occurring30 days were categorized as
Table I. Year of operation in octogenarians and patients a
repair
Year of
operation
Patients 80 years
N Column Row
1997 132 3.15 89.19
1998 338 8.06 89.51
1999 586 13.98 91.85
2000 728 17.37 87.20
2001 801 19.11 86.41
2002 800 19.09 82.48
2003 806 19.22 81.99
Column total 4191
The number of octogenarians treated by endovascular aneurysm repair incrlate deaths. Aneurysm-related deaths included 30-daydeaths and deaths that occurred as a result of aneurysm
rupture, endograft infection, or death 1 month after a
secondary surgical procedure for late complications of the
aneurysm.
Preoperative patient characteristics, comorbidity, risk
factors, aneurysmal morphology at the time of the initial
procedure, and details regarding the procedure and devices
were correlated with the defined study groups by univariate
analysis. Differences in findings between the two groups
were assessed univariate by 2 test for discrete variables and
by t test or Wilcoxon rank sum test, depending on distri-
bution, for continuous variables. Multivariate regression
analysis was used to correct for other risk factors. Outcomes
during follow-up were assessed univariate by life-table anal-
ysis. Significant differences between study groups were
assessed by log-rank testing. Multivariate analysis of time-
dependent variables was assessed by the Cox proportional
hazard model. P  .05 was considered to represent a
significant difference. All statistical analyses were performed
with SAS statistical software (v 8.0) (SAS Institute, Carey,
NC).
RESULTS
During the period 1996 to 2004, 697 patients aged
80 years were treated by EVAR for AAA, and their
operative and follow-up data were reported to the
EUROSTAR register. This age group represents 14% of
all patients in the register (Table I). The annual number
of enrolled octogenarians increased during the study
period (P  .0001); 68 were women (9.8%) (Table II),
and the mean age was 83 years (range, 80 to 100). In
patients80 years, the mean age was 70 years (range, 46
to 79). The mean age distribution in male and female
gender (83 years) was similar in the octogenarians. In the
younger patient group, the women were significantly
older than the men (72 vs 70 years, P  .0001). A total
of 4191 patients aged 80 years were used for controls.
As expected, risk factors were different in octogenarians
compared with younger patients (Table II). Cardiac and
pulmonary function was more frequently impaired. Smok-
ing, hyperlipidemia, and obesity were less frequent, and
80 years treated by endovascular abdominal aneurysm
Octogenarians
Row totalN Column Row
16 2.29 10.81 148
30 4.30 10.49 368
71 10.19 8.15 657
107 15.35 12.8 835
126 18.08 13.59 927
170 24.39 17.52 970
177 25.39 18.01 983
697 4433
during the study period (P  .0001).gedmore often an ankle-brachial index 0.87 was reported in
s varia
ries
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was reflected by a higher proportion of ASA classification
3 (P  .0001), and 32% of the octogenarians were
regarded unfit for open surgery (P  .0001).
Octogenarians had a slightly wider diameter of the
aneurysmal neck and maximum aneurysm diameter: 62 mm
compared with 58 mm in younger patients (Table III).
Aneurysmatic degeneration of the right or left common/
external iliac artery and also angulation of the neck and the
right and left iliac artery occurred more frequently in octo-
genarians. This is also reflected by a more frequent mor-
phologic classification D and E, which refer to aneurysm
involvement of the iliac arteries.
A number of distinct differences with regard to the
procedure and early outcome were observed in the group of
octogenarians. An aortouniiliac device was used more of-
ten, 8 vs 5%, respectively; and the duration of the procedure
as well as blood volume replacement were also higher in
elderly patients (Table IV). Moreover, octogenarians had a
longer stay in hospital, 7 vs 5.5 days, respectively. No
differences in the type of anesthesia administrated in the
two groups were observed.
The perioperative mortality of octogenarians was 5%
Table II. Patient demographic data, risk factors, and com
Patient characteristics
Patients 8
N  4191 (
Age at operation mean  SD (range) 70.3  6.5
Female gender 217
Ankle-brachial index 0.87 2388
Risks and comorbid factors
ASA class 3 1992
Smoking 1057
Hyperlipemia 1858
Impaired cardiac status 2454
Impaired renal function 736
Impaired pulmonary function 1716
Previous laparotomy 1087
Obesity 1131
Unfit for open surgery 914
Unfit for general anesthesia 322
ASA, American Society of Anaesthesiologists.
*Calculated by 2 analysis or t test for discrete variables and the continuou
Table III. Anatomic details
Aneurysm measurements
Pa
(
Neck diameter mean  SD (range) 23
Maximal aneurysmal diameter mean  SD (range) 57.6
Aneurysm in R or L comm or extern iliac
AAA-class D†, E†
Neck angulation
R iliac angulation
L iliac angulation
Blocking one internal iliac artery
*Calculations for categoric variables occurred by 2 analysis; for continuou
†Reflects progressively aneurysmatic degeneration of the common iliac artecompared with 2% in the younger group (Table V). Theperioperative all-cause complication rate was also higher in
octogenarians; this included endoleaks and several other
device- related and systemic complications. No significant
difference was observed in the early conversion rate be-
tween the two groups (1% and 1.6%, respectively). Even
after adjustment for other risk factors in the multivariate
analysis, octogenarians were independently associated with
more arterial, systemic, access site, lower-limb complica-
tions, and 30-day mortality rate (Table V).
The mean follow-up period was 14 months in octoge-
narians compared with 19 months in younger patients. The
completeness of follow-up data was 85%. During the fol-
low-up, the overall endoleak rate was higher in octogenar-
ians compared with younger patients (47% vs 28% endoleak
after 84 months, respectively) (Fig 1). More type II and
type III endoleaks were observed in octogenarians (Table
VI). A higher incidence of late complications was observed
during the follow-up period, and all-cause mortality and
aneurysm-related death were also higher in octogenarians.
No differences were observed in the incidence of conver-
sions and ruptures between the two groups. The mortality
during follow-up was higher in octogenarians (Fig 2).
Multivariate analysis revealed that being aged 80 years
ity
rs
)
Octogenarians
N  697 (14.3%) P*
9) 83.4  2.9 (80-100) .0001
68 (9.8) .0001
) 442 (63.4) .0014
) 411 (59.0) .0001
) 109 (15.6) .0001
) 230 (33.0) .0001
) 439 (63.0) .0276
) 167 (24.0) .0001
) 340 (48.8) .0001
) 212 (30.0) .0144
) 149 (21.44) .0018
) 222 (32.0) .0001
75 (10.9) .0055
ble, respectively.
s 80 years
4191) (%)
Octogenarians
(N  697) (%) P*
3.1 (9-40) 24.1  3.2 (12-38) .014
0.4 (40-145) 62.0  12.2 (40-122) .0001
32 (10.3) 95 (13.6) .0088
78 (13.8) 116 (16.6) .0458
08 (21.7) 207 (29.7) .0001
95 (30.9) 266 (38.2) .0001
85 (35.4) 327 (46.9) .0001
63 (20.1) 103 (24.6) .0337
bles, the Wilcoxon rank sum test was used.orbid
0 yea
85.7%
(43-7
(5.2)
(57.0
(47.5
(25.2
(44.3
(58.6
(17.6
(40.9
(26.0
(27.1
(21.9
(7.7)tient
N 
.8 
 1
4
5
9
12
14
5
s variawas an independent factor for higher mortality (P .0001)
test for these continuous variables.
ue was calculated by multivariate regression analysis.
with endovascular aneurysm repair.
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VI).
DISCUSSION
A hospital mortality of 5% in a group of patients 80
years is on the lower end of the range of reported mortality
rates in series treated by open surgery, where the early
mortality varies from 5% to 10.5%.3,4,19 Dardik et al20 and
co-workers demonstrated a significant increase in the death
rate after elective AAA repair with advanced age, from 2.2%
for patients in the sixth decade of life to 7.3% for octoge-
narians. The rate of complication, in particular the systemic
events, although higher than in younger patients, appears
acceptable. The overall rate was 13%. Most of these sys-
temic complications were cardiac, pulmonary, and renal
adverse events. Although one would assume that these
complications might adversely influence the quality of life,
objective assessments on this matter have not been per-
formed in the elderly age group.
One should consider that this group of elderly patients
has significant comorbidities. A proportion as high as 32%
Table IV. Procedural details, anesthesia and stay in hospit
Procedure demographics
Pat
Aortouniiliac device
Duration of procedure (min) mean  SD (range) 128.9
General anesthesia
Regional anesthesia
Local anesthesia
Replaced blood volume (mL) mean  SD (range) 522.5
Days until discharge mean  SD (range) 5
Follow-up (months) mean  SD (range) 18.9
*Calculated by 2 analysis for discrete variables and by Wilcoxon rank sum
Table V. Early outcome
Early complications
Patients 80 years
(N  4191) (%)
O
(
Type I - Proximal endoleak 106 (2.5)
Device related complications 200 (4.8)
Inability to deploy stent 15 (0.4)
Arterial complications 138 (3.3)
Systemic complications 452 (10.8)
Cardiac 115 (2.8)
Cerebral 28 (0.7)
Pulmonary 70 (1.7)
Renal 77 (1.8)
Access site & lower limb compl. 240 (5.7)
Bleeding, hematoma, false an. 132 (3.2)
Arterial thrombosis 17 (0.4)
Early death 89 (2.1)
Early conversion 40 (1.0)
Early rupture 1 (0.02)
OR, Odds ratio; CI, confidence interval.
*Calculated by 2 analysis
†Ajusted for gender, American Society of Anaesthesiologists class, Society of
for open surgery, general anesthesia, and aneurysm size. The adjusted P valal
ients  80 years
(N  4191)
Octogenarians
(N  697) P*
212 (5.1%) 54 (7.8%) .0038
 55.9 (25-660) 140.0  59.0 (30-450) .0001
2947 (70.3%) 485 (69.6%) NS
1012 (24.2%) 180 (25.8%) NS
232 (5.5%) 32 (4.6%) NS
 640.4 (2-6000) 726.0  833.2 (40-5000) .0039
.5  7.5 (0-165) 7.3  9.9 (0-108) .0001
 18.6 (0-84) 14.3  13.7 (0-72) .0001ctogenarians
N  697) (%) P*
Adjusted
P† OR 95% CI
28 (4.0) .0259 NS .67 .43-1.04
48 (6.9) .0185 .05 .71 .50-1.00
8 (1.2) .0048 NS .43 .16-1.15
39 (5.6) .0026 0.026 .65 .44-.95
135 (19.4) .0001 .0001 .57 .45-.71
52 (7.5) .0001 .0001 .40 .27-.57
10 (1.4) .0329 NS .56 .26-1.19
31 (4.5) .0001 .0004 .50 .31-.81
24 (3.5) .0058 .019 .55 .34-.91
74 (10.6) .0001 .0001 .56 .41-.75
50 (7.2) .0001 .0002 .45 .35-.72
7 (1.0) .0363 .0217 .33 .13-.85
38 (5.5) .0001 .0007 .48 .31-.73
11 (1.6) NS NS .58 .29-1.18
— NS NS — —
Vascular Surgery/International Society of Vascular Specialists risk scores, unfitnesswere regarded unfit for open repair.21 Previous studies haveFig 1. Kaplan-Meier graph represents cumulative freedom from
any endoleak in patients operated for abdominal aortic aneurysm
app
ion or
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outcome after EVAR.16,22 There was an increasing per-
centage of octogenarians treated by EVAR during the study
period. A 10-fold increase of admissions of octogenarians
has been reported by Reiss et al.23 The same investigators
found an increase in the number of operations in octoge-
narians, from 1.1% to 5.1%, relative to all operations per-
formed in one hospital during the period 1973 to 1989.
This may reflect a growing population of octogenarians, as
well as a greater expectation of a successful outcome of
surgery in this group of patients. Improved postoperative
Table VI. Outcome during follow-up
Late complications
Patients 80 years
(N  4191)
Octog
(N
Overall mortality 392 (9.4%) 109
Late mortality 303 (7.2%) 71
AAA-related death 117 (2.8%) 49
Overall conversion 95 (2.3%) 18
Late conversion 55 (1.3%) 9
Overall rupture 19 (0.5%) 3
Late rupture 18 (0.4%) 3
N  4079‡ N 
Endoleaks 677 (16.2%) 148
Type I - proximal 97 (2.4%) 21
Type I - distal 72 (1.8%) 17
Type II 140 (3.4%) 33
Type III 483 (11.8%) 97
Aneurysm growth 8 mm 253 (6.7%)† 46
HR, Hazard rate; CI, confidence interval.
*Calculated by log-rank analysis
†N3797 / N 604 Adjusted for follow-up time, gender, American Societ
Vascular Specialists risk scores, unfitness for open surgery, general anaesthe
hazard model.
‡Patients who had no follow-up visits (who suffered an early death, convers
Fig 2. Kaplan-Meier graph represents long-term survival after
endovascular repair of abdominal aortic aneurysm in octogenarians
and patients aged 80 years.care, anesthesia, and surgical methods may have promotedthis development. In addition, increased experience with
EVAR and newer generations of stent grafts have led to
fewer complications than in the earlier years of EVAR.24
Elderly patients may especially benefit from this improve-
ment.25
Octogenarians have a relatively high incidence of renal,
pulmonary, and cardiac disease, which may explain why
they often are regarded unfit for open surgery and why
EVAR increasingly was selected as the preferred treatment.
When a decision is made on which patients will be treated
by open repair, it is likely that those with the most severe
comorbidity or decreased life expectancy will be excluded.
Ironically, this may lead to the exclusion of patients with
the largest aneurysm and highest risk of rupture. This larger
size observed in octogenarians may reflect a common ten-
dency by referring physicians to delay referral of patients in
this age group for surgical repair.10
The association between comorbidity and aneurysm
diameter has been demonstrated previously.26 One study
assessing the risk of rupture in nonoperated aneurysm
indicated an annual rupture rate of 18.6% when the diam-
eter was 60 mm.27 In the present series, only three
ruptures (0.4%) occurred after EVAR in the octogenarian
study group during a follow-up period of 72 months. This
is in agreement with the observation that if, perhaps, EVAR
does not avert the risk of rupture entirely, it will be associ-
ated with a reduction of at least 96%.However, the
raisal of the net effect of any intervention in patients
with advanced age is difficult because of the high natural
mortality and complication rate.
Some of the anatomic details, such as a larger diameter
of the aneurysm neck, a higher incidence of angulation of
the neck or the iliac arteries, and more type D and E
aneurysms, may indicate that the disease was more ad-
ans
) P*
Adjusted
P† HR 95% CI
%) .0001 .0001 1.65 1.32-2.06
%) .0001 .0021 1.53 1.17-2.01
) .0001 .0001 2.15 1.52-3.05
) NS NS 1.35 .81-2.27
) NS NS 1.03 .46-2.29
) NS NS 1.18 .34-4.06
) NS NS 1.25 .36-4.34
‡
%) .0001 .0001 1.46 1.21-1.76
) NS NS 1.29 .79-2.12
) NS NS 1.65 .94-2.89
) .0044 .0059 1.87 1.20-2.91
%) .0030 .0056 1.40 1.10-1.76
)† .0020 NS 1.26 .92-1.73
naesthesiologists class, Society of Vascular Surgery/International Society of
d aneurysm size. The adjusted p-value calculated by the Cox proportional
rupture) were excluded.enari
 697
(15.9
(10.2
(7.0%
(2.6%
(1.0%
(0.4%
(0.4%
655
(21.2
(3.2%
(2.6%
(5.0%
(14.8
(7.6%
y of A
sia anvanced in octogenarians than in younger patients. They
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similar observation has been made in patients with ruptured
aneurysm28 and it has been suggested that the results after
EVAR are less favorable the larger the aneurysm.26 It is
possible that better endoprostheses and the development of
a possibility to apply side branches or fenestration may
overcome these problems. However, failure to complete
the endovascular procedure in this series occurred only in
11 of the 696 octogenarians.
After elective open repair of AAA, the quality of life may
return to the preoperative status, although it may take from
3 to 6 months to recover completely from surgery.29 In one
study, 36% of patients operated with open technique expe-
rienced a permanent lack of recovery to preoperative status,
and 18% expressed the opinion that they would not choose
again to undergo this operation.30 After EVAR, the health-
related quality of life in the long run is similar to that
observed after open surgery,31 but a better quality of life
was observed in the first postoperative month after
EVAR.32 The more rapid normalization of physical and
psychologic functions could be particularly important for
the recovery in elderly patients.25
Although there were significant differences between
the two groups regarding procedural details, the overall
impact of the procedure in the elderly was within reason-
able limits. The longer stay in
narians is lower than after open repair.33,34 As expected, the
hospital of 7 days in octoge-
complication rate was somewhat higher among octogenar-
ians compared with younger patients. Procedural compli-
cations such as endoleak were only slightly more frequent in
elderly patients. A higher incidence of hemorrhagic com-
plications has also been observed after open surgery.19 No
difference in the rate of conversion to open surgery or
rupture rate was observed during the follow-up period
compared with the younger group. With a low event rate,
however, it is possible that the lack of statistical power
could disguise differences. An increased late mortality
probably reflects the natural course in a cohort of octoge-
narians. O’Hara et al6 reported an overall death rate of 9.6%
in a 10-year period in a large series of electively treated
octogenarians.
As a greater proportion of the population lives longer,
the complexity of surgical therapy in the elderly becomes an
increasing concern and calls for less-invasive surgical treat-
ment. Life expectancy, risks of the procedure, and postop-
erative quality of life play an important role in the decisions
made by patients, surgeons, and anesthesiologists.10 This
concern is highlighted by the fact that there are currently at
least 4 million octogenarians in the United States, a figure
expected to grow to as high as 30 million by 2050.35
CONCLUSION
Our study supports that EVAR might be considered
when treating elderly patients who have a limited life ex-
pectancy, provided their aneurysms are anatomically suited
for the endovascular technique.9-11 The risk for late com-
plications compared with open repair may be outweighedby a lower early mortality and a shorter time for physical
recovery.13,15,33
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